Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Polyclonal Antibody

Anti-EV71 VP3/Capsid protein VP3 Polyclonal Antibody

Catalog #:   PVV20501 Specific References (28) DATASHEET
Host species: Rabbit
Isotype: IgG
Applications: ELISA, IHC, WB
Accession: B9VUU3
Overview

Catalog No.

PVV20501

Species reactivity

Human enterovirus 71 (EV71) (EV-71)

Host species

Rabbit

Isotype

IgG

Clonality

Polyclonal

Immunogen

E. coli - derived recombinant EV71 VP3/Capsid protein VP3 (Gly324-Gln565).

Tested applications

ELISA: 1:4000-1:8000, WB: 1:1000-1:4000

Target

Genome polyprotein, P1, Capsid protein VP3, P1C, Virion protein 3

Purification

Purified by antigen affinity column.

Accession

B9VUU3

Applications

ELISA, IHC, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Data Image
  • Western Blot
    Recombinant Protein lysates were subjected to SDS PAGE followed by western blot with VP3/Capsid protein VP3 antibody (PVV20501) at 1 μg/ml.

    Lane 1: Recombinant protein

    Second Ab: Goat Anti-Rabbit IgG H&L Polyclonal antibody, HRP (PTB96431) at 0.1 μg/mL.

    Predict MW: 53 kDa
    Observed MW: 53 kDa
References

Chemokine PF4 Inhibits EV71 and CA16 Infections at the Entry Stage., PMID:35579435

Chimeric enterovirus 71 virus-like particle displaying conserved coxsackievirus A16 epitopes elicits potent immune responses and protects mice against lethal EV71 and CA16 infection., PMID:34116877

Structural and functional analysis of protective antibodies targeting the threefold plateau of enterovirus 71., PMID:33067459

Development and characterization of an enterovirus 71 (EV71) virus-like particles (VLPs) vaccine produced in Pichia pastoris., PMID:31403352

Enterovirus type 71-immunized chicken egg yolk immunoglobulin has cross antiviral activity against coxsackievirus A16 in vitro., PMID:31258670

Preparation and identification of chicken egg yolk immunoglobulins against human enterovirus 71 for diagnosis of hand-foot-and-mouth disease., PMID:30831098

Analysis of an Imported Subgenotype C2 Strain of Human Enterovirus 71 in Beijing, China, 2015., PMID:30323801

Poorly neutralizing polyclonal antibody in vitro against coxsackievirus A16 circulating strains can prevent a lethal challenge in vivo., PMID:29337652

Effective in vivo therapeutic IgG antibody against VP3 of enterovirus 71 with receptor-competing activity., PMID:28422137

Vesicular stomatitis virus-based vaccines expressing EV71 virus-like particles elicit strong immune responses and protect newborn mice from lethal challenges., PMID:27373596

Protein microarray-mediated detection of antienterovirus antibodies in serum., PMID:26831405

EV71 virus-like particles produced by co-expression of capsid proteins in yeast cells elicit humoral protective response against EV71 lethal challenge., PMID:26809443

A new EV71 VP3 epitope in norovirus P particle vector displays neutralizing activity and protection in vivo in mice., PMID:26529072

Characterization of the antibody response against EV71 capsid proteins in Chinese individuals by NEIBM-ELISA., PMID:26023863

Recombinant adeno-vaccine expressing enterovirus 71-like particles against hand, foot, and mouth disease., PMID:25855976

Long-term immunogenicity studies of formalin-inactivated enterovirus 71 whole-virion vaccine in macaques., PMID:25197967

Concentration and purification of enterovirus 71 using a weak anion-exchange monolithic column., PMID:24884895

A novel universal neutralizing monoclonal antibody against enterovirus 71 that targets the highly conserved "knob" region of VP3 protein., PMID:24875055

VP2 dominated CD4+ T cell responses against enterovirus 71 and cross-reactivity against coxsackievirus A16 and polioviruses in a healthy population., PMID:23863902

Analysis and solution of false-positives when testing CVA16 sera using an antibody assay against the EV71 virus., PMID:23707400

Immunological and biochemical characterization of coxsackie virus A16 viral particles., PMID:23226233

Characterization of enterovirus 71 capsids using subunit protein-specific polyclonal antibodies., PMID:23046991

Immunological evaluation and comparison of different EV71 vaccine candidates., PMID:23008736

Enterovirus 71 viral capsid protein linear epitopes: identification and characterization., PMID:22264266

Purification and characterization of enterovirus 71 viral particles produced from vero cells grown in a serum-free microcarrier bioreactor system., PMID:21603631

Identification and characterization of a cross-neutralization epitope of Enterovirus 71., PMID:21501643

Detection, characterization and quantitation of coxsackievirus A16 using polyclonal antibodies against recombinant capsid subunit proteins., PMID:21295614

Genetic analysis of the VP1 region of human enterovirus 71 strains isolated in Korea during 2000., PMID:14505086

Datasheet
$ 170
Product specifications
50 μg 170 100 μg 280

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-EV71 VP3/Capsid protein VP3 Polyclonal Antibody [PVV20501]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only